[Effect of new phthalazine derivative, N-1 carboethoxy-N-2-phthalazino-hydraines (Binazin), on vascular noradrenergic receptors].
D000818:Animals; D001808:Blood Vessels / Q000294:innervation; D002264:Carboxylic Acids / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D006571:Heterocyclic Compounds / Q000494:pharmacology; D006834:Hydrazines / Q000494:pharmacology*; D009638:Norepinephrine / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D011984:Sensory Receptor Cells / Q000187:drug effects*; D014666:Vasomotor System / Q000187:drug effects
D002264:Carboxylic Acids; D006571:Heterocyclic Compounds; D006834:Hydrazines; D009638:Norepinephrine; D004837:Epinephrine
Wpływ nowej pochodnej ftalazyny N1-karboetoksy-N2-ftalazyno-hydrazyny na noradrenalinowe receptory naczyniowe.